These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6126765)
1. Ca antigen is not Thomsen-Friedenreich antigen. Harris H; Bramwell ME; McGee JO Lancet; 1982 Oct; 2(8304):925-6. PubMed ID: 6126765 [No Abstract] [Full Text] [Related]
2. The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule. Dippold W; Steinborn A; Meyer zum Büschenfelde KH Environ Health Perspect; 1990 Aug; 88():255-7. PubMed ID: 2272320 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers. Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463 [TBL] [Abstract][Full Text] [Related]
4. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test. Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780 [TBL] [Abstract][Full Text] [Related]
5. The human repertoire of antibody specificities against Thomsen-Friedenreich and Tn-carcinoma-associated antigens as defined by human monoclonal antibodies. Jansson B; Borrebaeck CA Cancer Immunol Immunother; 1992; 34(5):294-8. PubMed ID: 1540975 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the Thomsen-Friedenreich antigen. MacLean GD; Longenecker BM Semin Cancer Biol; 1991 Dec; 2(6):433-9. PubMed ID: 1810470 [TBL] [Abstract][Full Text] [Related]
7. Blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity from human liver metastatic carcinomas. Otsuka K; Kudo T; Nakajima T; Ohkuma S Int J Biochem; 1991; 23(5-6):569-78. PubMed ID: 1648519 [TBL] [Abstract][Full Text] [Related]
8. [Expression of Thomsen-Friedenreich antigen (T-Ag) in gynecologic cancer tissues]. Sakamoto Y; Kamada M; Shitsukawa K; Yasui T; Furumoto H; Mori K; Daitoh T; Irahara M; Kishi Y; Aono T Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1980-6. PubMed ID: 3429980 [TBL] [Abstract][Full Text] [Related]
9. Association of exposed Thomsen-Friedenreich antigen (T antigen) and acute renal failure in septic patients. Lenz G; Goes U; Baron D; Junger H; Heller W; Sugg U; Lissner R Lancet; 1984 Feb; 1(8371):292-3. PubMed ID: 6143038 [No Abstract] [Full Text] [Related]
10. Computational screening of the human TF-glycome provides a structural definition for the specificity of anti-tumor antibody JAA-F11. Tessier MB; Grant OC; Heimburg-Molinaro J; Smith D; Jadey S; Gulick AM; Glushka J; Deutscher SL; Rittenhouse-Olson K; Woods RJ PLoS One; 2013; 8(1):e54874. PubMed ID: 23365681 [TBL] [Abstract][Full Text] [Related]
11. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen. Stein R; Chen S; Grossman W; Goldenberg DM Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799 [TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of blood group N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity, N antigen precursor glycoproteins and T-active glycoproteins from cyst fluids of malignant ovarian clear cell carcinoma. Yanagi K; Ohyama K; Yamakawa T; Ohkuma S Int J Biochem; 1990; 22(9):1015-28. PubMed ID: 2282960 [TBL] [Abstract][Full Text] [Related]
13. [Clinical implication of serum antibody to Thomsen-Friedenreich antigen in patients with gynecological malignancies]. Yasui T; Sakamoto Y; Ueda T; Maeda N; Shitsukawa K; Furumoto H; Mori K; Daitoh T; Irahara M; Kamada M Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):583-7. PubMed ID: 3385276 [TBL] [Abstract][Full Text] [Related]
14. [Myelodysplastic syndrome with Th-polyagglutination]. Akahonai Y; Tanimura A; Nakagawa N; Mori M; Kawasaki K; Kobayashi T; Yachi A; Ishii Y Rinsho Ketsueki; 1986 Jan; 27(1):54-9. PubMed ID: 3712781 [No Abstract] [Full Text] [Related]
15. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Yuan M; Itzkowitz SH; Boland CR; Kim YD; Tomita JT; Palekar A; Bennington JL; Trump BF; Kim YS Cancer Res; 1986 Sep; 46(9):4841-7. PubMed ID: 3731131 [TBL] [Abstract][Full Text] [Related]
16. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation. Cairns T; Lee J; Goldberg LC; Hakim N; Cook T; Rydberg L; Samuelsson B; Taube D Transplant Proc; 1996 Apr; 28(2):795-6. PubMed ID: 8623404 [No Abstract] [Full Text] [Related]
18. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines. Wolf MF; Koerner U; Schumacher K Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954 [TBL] [Abstract][Full Text] [Related]
19. [Different expressions of various epitopes of the Thomsen-Friedenreich antigen in breast cancer cells. Immunohistochemical study with monoclonal antibodies against asialoglycophorin A]. Bein G; Poschmann A; Seitz RC; Böcker W Verh Dtsch Ges Pathol; 1985; 69():218-21. PubMed ID: 2420088 [No Abstract] [Full Text] [Related]
20. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma. Weinstein RS; Miller AW; Coon JS Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282 [No Abstract] [Full Text] [Related] [Next] [New Search]